DNMT3B and acute myeloid leukemia: It is well known that methylation of promoter and exon regions is one of the major regulatory mechanisms of gene expression; thus, we hypothesized that genetic variants of DNMT3B may be responsible for regulating the methylation status of other genes associated with AML risk.